Gad, GLP-1 and weight loss

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Salk scientists identify protein BCL6 as a key regulator of muscle maintenance in mice; BCL6-enhancing therapies may prevent ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
A new peer-reviewed study based on data from nearly 2M individuals highlights a wide range of clinical benefits and risks, ...
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
Over 2 million people were included in new research to test these drugs against 175 different health outcomes.
Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...
In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...
Shares of Novo Nordisk NVO gained 8.5% on Friday after the company announced positive top-line data from an early to ...